Wellness and prevention must drive India’s next healthcare push: Dr. Jitendra Singh
Singh also highlighted the role of science and technology in tackling emerging healthcare challenges
Singh also highlighted the role of science and technology in tackling emerging healthcare challenges
The system combines a Riva Anchor SI joint fusion implant with the company’s Riva Posterior Pedicle Fixation System
Under the agreement, LIB Therapeutics will receive upfront and milestone payments, plus net sales royalties
The transaction was executed via Dr. Lal PathLabs FZCO
Biocon Malaysia bags UK MHRA nod for new Insulin fill-finish line
Under the terms of the deal, Jagsonpal will pay an upfront initial consideration of Rs. 23.7 crore at closing
Zydus Lifesciences' New Jersey Office clears USFDA inspection with zero observations
The company had earlier intimated that Phase I of the Greenfield facility commenced commercial production with effect from March 11, 2025
IOL Chemicals and Pharmaceuticals obtains EU-REACH registration for Triacetin
New research shows alpha-hydroxybutyrate can identify increased type 2 diabetes risk nearly a decade before diagnosis; DirectSens technology enables routine clinical chemistry testing
The Health & Pharma Business Unit continued to face intense competition and pricing pressure
Targets 10 million more young people by 2030
The new 1.29 lakh sq. ft. facility integrates molding, extrusion, and cleanroom manufacturing, expanding SJML’s precision medical component and diagnostic capabilities
The programme will establish a scalable manufacturing process for CanVirex's lead candidate, expressing IL-12, targeting advanced solid tumours
Under the agreement, Boehringer Ingelheim will evaluate selected targets identified through Envisagenics’ AI-powered SpliceCore platform
Enveda said the new capital will be used to move ENV-294 and ENV-308 into later-stage trials
The platform will combine expert perspectives and scientific insights with practical analytical approaches, live technology demonstrations and peer-to-peer discussions
The partnership pairs BoomRay's early-stage precision oncology R&D with Novartis's established global scale in the radiopharmaceutical sector
Subscribe To Our Newsletter & Stay Updated